Dana-Farber Cancer Institute

Researchers identify early sign of pancreatic cancer

Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer – an upsurge in certain ...

Sep 28, 2014
popularity 4.5 / 5 (28) | comments 0

Oral inhibitor shows clinical activity in poor-prognosis AML

An oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) - a poor-prognosis group with few options - report investigators ...

Dec 08, 2014
popularity not rated yet | comments 0